Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant creutzfeldt-jakob disease transmission

Neuropathology and Applied Neurobiology

Volumn 35, Issue 4, 2009, Pages 433-436

  Head, M W ^a   Yull, H M ^a   Ritchie, D L ^a   Bishop, M T ^a   Ironside, J W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN;

ADULT; BLOOD DONOR; BLOOD TRANSFUSION; CASE REPORT; CELL LOSS; DISEASE TRANSMISSION; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; RECIPIENT; VARIANT CREUTZFELDT JAKOB DISEASE; WESTERN BLOTTING;

BLOOD DONORS; BLOOD TRANSFUSION; BLOTTING, WESTERN; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PRIONS; YOUNG ADULT;

EID: 67649995088     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2009.01025.x     Document Type: Letter

References (14)

1. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousins S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004 363 : 417 21
2. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004 365 : 527 9
3. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Lineham JM, Brandner S, Wadsworth JDF, Hewitt P, Collinge J. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006 368 : 2061 7
4. Health Protection Agency. Fourth case of transfusion-associated variant CJD infection. Health Protection Report. Available at: http://www.hpa.org.uk/ hpr/archives/2007/news2007/news0307.htm (last accessed 20 April 2009)
5. Hewitt P, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review. Vox Sang 2006 91 : 221 30
6. Bishop MT, Ritchie DL, Will RG, Ironside JW, Head MW, Thomson V, Bruce M, Manson JC. No major change in vCJD agent strain after secondary transmission via blood transfusion. PLoS ONE 2008 8 : e2878
7. Head MW, Ritchie DL, Smith N, McLoughlin V, Nailon W, Samad S, Masson S, Bishop M, McCardle L, Ironside JW. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfelt-Jakob disease. Am J Pathol 2004 164 : 143 53
8. Head MW, Bunn TJ, Bishop M, McLoughlin V, Lowrie S, McKimmie CS, Williams MC, McCardle L, Mackenzie J, Knight R, Will RG, Ironside JW. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease. Ann Neurol 2004 55 : 851 9
9. Ironside JW, Head MW, Bell JE, McCardle L, Will RG. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000 37 : 1 9 (Pubitemid 30496729)
10. The National CJD Surveillance Unit. CJD Statistics. Available at: http://www.cjd.ed.ac.uk/figures.htm (last accessed 20 April 2009)
11. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, Ritchie DL, McCardle LM, Hilton DA. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 2006 332 : 1186 65
12. st century - an acquired human prion disease with very long incubation periods. Lancet 2006 367 : 2068 74
13. Clarke P, Will RG, Ghani AC. Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 2007 4 : 675 84
14. Walker JT, Dickson J, Sutton JM, Marsh PD, Raven ND. Implications for Creutzfeldt-Jakob disease (CJD) in dentistry: a review of current knowledge. J Dent Res 2008 87 : 511 19